Loading company
Latest annual · FY2025
Millions- Total revenues
- 50
- Gross profit
- 50
- Operating income
- (49)
- Net income
- (50)
Latest quarter · Q3 FY2026
Millions- Total revenues
- 11
- Gross profit
- 11
- Operating income
- (14)
- Net income
- (14)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- +610.3%
- Revenue, 5 yearsFY2020 to FY2025
- +15.7%
- Net income, 5 yearsFY2020 to FY2025
- n/m
LEXICON PHARMACEUTICALS, INC. (LXRX) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $49.8 million | $31.1 million | +60.2% | 10-K 2026-03-05 · proof |
| Gross profit | $49.5 million | $30.5 million | +62.6% | 10-K 2026-03-05 · proof |
| Operating income | -$48.9 million | -$197.1 million | 10-K 2026-03-05 · proof | |
| Net income | -$50.3 million | -$200.4 million | 10-K 2026-03-05 · proof | |
| Cash from operating activities | -$67.9 million | -$178.8 million | 10-K 2026-03-05 · proof | |
| Free cash flow | -$67.9 million | -$179.8 million | 10-K 2026-03-05 · proof | |
| Total assets | $185 million | $298.4 million | -38% | 10-K 2026-03-05 · proof |
| Total liabilities | $77.4 million | $152.5 million | -49.2% | 10-K 2026-03-05 · proof |
| Cash and cash equivalents | $34.3 million | $66.7 million | -48.5% | 10-K 2026-03-05 · proof |
| Total debt | $54 million | $100.3 million | -46.2% | 10-K 2026-03-05 · proof |
- What was LEXICON PHARMACEUTICALS, INC. (LXRX)'s revenue in fiscal 2025?
- LEXICON PHARMACEUTICALS, INC. (LXRX) reported revenue of $49.8 million for fiscal 2025 (the year ended Dec 31, 2025), against $31.1 million the year before (+60.2%). Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
- What was LEXICON PHARMACEUTICALS, INC. (LXRX)'s gross profit in fiscal 2025?
- LEXICON PHARMACEUTICALS, INC. (LXRX) reported gross profit of $49.5 million for fiscal 2025 (the year ended Dec 31, 2025), against $30.5 million the year before (+62.6%). Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
- What was LEXICON PHARMACEUTICALS, INC. (LXRX)'s operating income in fiscal 2025?
- LEXICON PHARMACEUTICALS, INC. (LXRX) reported operating income of -$48.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$197.1 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
- What was LEXICON PHARMACEUTICALS, INC. (LXRX)'s net income in fiscal 2025?
- LEXICON PHARMACEUTICALS, INC. (LXRX) reported net income of -$50.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$200.4 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
- What was LEXICON PHARMACEUTICALS, INC. (LXRX)'s cash from operating activities in fiscal 2025?
- LEXICON PHARMACEUTICALS, INC. (LXRX) reported cash from operating activities of -$67.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$178.8 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
- What was LEXICON PHARMACEUTICALS, INC. (LXRX)'s free cash flow in fiscal 2025?
- LEXICON PHARMACEUTICALS, INC. (LXRX) reported free cash flow of -$67.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$179.8 million the year before. Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
- What are LEXICON PHARMACEUTICALS, INC. (LXRX)'s total assets?
- As of Dec 31, 2025, LEXICON PHARMACEUTICALS, INC. (LXRX) reported total assets of $185 million, against $298.4 million a year earlier (-38%). Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
- What are LEXICON PHARMACEUTICALS, INC. (LXRX)'s total liabilities?
- As of Dec 31, 2025, LEXICON PHARMACEUTICALS, INC. (LXRX) reported total liabilities of $77.4 million, against $152.5 million a year earlier (-49.2%). Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
- What are LEXICON PHARMACEUTICALS, INC. (LXRX)'s cash and cash equivalents?
- As of Dec 31, 2025, LEXICON PHARMACEUTICALS, INC. (LXRX) reported cash and cash equivalents of $34.3 million, against $66.7 million a year earlier (-48.5%). Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
- What is LEXICON PHARMACEUTICALS, INC. (LXRX)'s total debt?
- As of Dec 31, 2025, LEXICON PHARMACEUTICALS, INC. (LXRX) reported total debt of $54 million, against $100.3 million a year earlier (-46.2%). Source: the 10-K filed with the SEC on Mar 5, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:LXRX&period_type=annual&limit=5"Information only, not investment advice.